Literature DB >> 7676636

Sequence characterization and comparison of human adenovirus subgenus B and E hexons.

P Pring-Akerblom1, F E Trijssenaar, T Adrian.   

Abstract

The hexon genes of human adenovirus (AV) types 3, 16 (both subgenus B), and 4 (subgenus E) were sequenced and the nucleotide and predicted amino acid sequences were compared. We observed a high degree of homology between the three serotypes and thus could confirm the close evolutionary relationship of subgenera B and E which was previously inferred after comparing other genome regions. Employing the three-dimensional model of the AV2 hexon, the structures of the three hexons were predicted. The major differences between the hexons of AV3/AV16 and AV3/AV4 were confined to the I1 and I2 surface loops. As expected from cross-reactions in neutralization, the hexons of AV16 and AV4 were not only very homologous in the conserved regions but also in the loops I1 and I2. This indicates that the type-specific antigenic determinant is located in these regions of the hexon. Closer examination of the loop I4 sequences, including also serotypes of subgenera A, C, and F, revealed that this region is subgenus-specific. The finding that AV4 differs from AV3 and AV16 in loop 1(4) supports the placement of AV4 in a separate subgenus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7676636     DOI: 10.1006/viro.1995.1474

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Rapid typing of human adenoviruses by a general PCR combined with restriction endonuclease analysis.

Authors:  A Allard; B Albinsson; G Wadell
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  Adenovirus strains of subgenus D associated with nosocomial infection as new etiological agents of epidemic keratoconjunctivitis in Japan.

Authors:  S Takeuchi; N Itoh; E Uchio; K Tanaka; N Kitamura; H Kanai; K Isobe; K Aoki; S Ohno
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

3.  Strain variation in adenovirus serotypes 4 and 7a causing acute respiratory disease.

Authors:  L K Crawford-Miksza; R N Nang; D P Schnurr
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

4.  Identification of the hexon region of an adenovirus involved in a new outbreak of keratoconjunctivitis.

Authors:  Y Imai; S Kameya; M Ohkoshi; K Yamaki; S Sakuragi
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

5.  PCR and restriction endonuclease analysis for rapid identification of human adenovirus subgenera.

Authors:  E M Elnifro; R J Cooper; P E Klapper; A S Bailey
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

6.  Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.

Authors:  Ijad Madisch; Gabi Harste; Heidi Pommer; Albert Heim
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Comparative sequence analysis of the hexon gene in the entire spectrum of human adenovirus serotypes: phylogenetic, taxonomic, and clinical implications.

Authors:  K Ebner; W Pinsker; T Lion
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

8.  Molecular evolution of human adenovirus type 16 through multiple recombination events.

Authors:  Xingui Tian; Hongkai Wu; Rong Zhou
Journal:  Virus Genes       Date:  2019-08-05       Impact factor: 2.332

9.  Serotyping of adenoviruses on conjunctival scrapings by PCR and sequence analysis.

Authors:  S Takeuchi; N Itoh; E Uchio; K Aoki; S Ohno
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

10.  Computational analysis of four human adenovirus type 4 genomes reveals molecular evolution through two interspecies recombination events.

Authors:  Shoaleh Dehghan; Jason Seto; Elizabeth B Liu; Michael P Walsh; David W Dyer; James Chodosh; Donald Seto
Journal:  Virology       Date:  2013-06-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.